DNA recognition by lexitropsins, minor groove binding agents

Area of Science:

• Molecular Biology
• Medicinal Chemistry
• Genetics

Background:

• DNA sequence selective binding agents have potential applications in cancer diagnosis and treatment.
• Antisense approaches are established for cellular intervention and gene control.
• Alternative strategies are needed for enhanced specificity and efficacy.

Purpose of the Study:

• Introduce lexitropins as information-reading molecules for antigene strategies.
• Discuss factors influencing lexitropin design and molecular recognition.
• Explore the therapeutic potential of novel lexitropins.

Main Methods:

• Review of chemical, physical, and pharmacological factors in lexitropin design.
• Analysis of molecular recognition principles, including hydrogen bonding, shape, and charge.
• Discussion of experimental results illustrating lexitropin efficacy.

Main Results:

• Lexitropins function as an alternative/complementary approach to antisense strategies.
• Key factors for molecular recognition include hydrogen bonding, shape, chirality, and phasing for longer ligands.
• A 2:1 lexitropin-DNA binding motif allows discrimination between GC and CG base pairs.
• Novel lexitropins demonstrate anticancer, antiviral, and antiretroviral properties, and inhibit topoisomerases.

Conclusions:

• Lexitropin design principles enable the creation of sequence-selective DNA binding agents.
• These agents hold significant therapeutic potential for various diseases, including cancer.
• Evidence suggests a correlation between agent selectivity and biological response, paving the way for targeted therapies.